Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

7,8-DHC7,8-Dihydrocannabinol

Intermediate between THC and CBN, an oxidation trace and a semi-synthetic product; never studied.

Harm-reduction warning

No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.

C₂₁H₂₈O₂

CID 94376

Family
Semi-synthetic cannabinoidProvisional classification
Molar mass
312.45 g/mol

Updated on

In plain terms

7,8-DHC is an intermediate molecule between THC and CBN: it forms in trace amounts when THC oxidises, and it has also been offered on the grey market in semi-synthetic form. Its pharmacology has never been studied. In France, since June 2024 it falls under the generic clause that classifies benzo[c]chromene derivatives as narcotics.

Receptors and activity

    Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

    Pharmacology

    7,8-Dihydrocannabinol sits between Δ9-THC and cannabinol: its terpene ring carries an extra double bond at 6a,10a, which brings it closer to cannabinol without fully aromatising it. Hanuš et al. (2016) cite its isolation as evidence for the artefactual origin of CBN-type cannabinoids, formed by oxidative aromatisation of THC. Caprari et al. (2024) list it among the semi-synthetic cannabinoids discussed by users, obtained from Δ9-THC according to a patent, and state that effects close to those of Δ9-THC are expected. No CB1 or CB2 binding assay has been published; a 2020 computational analysis predicts greater susceptibility to liver metabolism, without experimental validation. No human or toxicological data are published. In France, since June 2024 it falls under the generic "benzo[c]chromene" clause of the narcotics list.

    History

    Source
    7,8-DHC is a partially aromatised intermediate between Δ9-THC and cannabinol. The critical review by Hanuš et al. (2016) cites its isolation as evidence for the artefactual origin of CBN-type cannabinoids, formed by oxidative aromatisation of THC-type derivatives: it is therefore present in cannabis as a degradation product, in trace amounts, even though the original isolation paper was not found. It also exists as a semi-synthetic product: Caprari et al. (2024) list it among the "pseudo-natural" cannabinoids discussed on user forums, prepared according to a patent (Loewinger et al.) from Δ9-THC, itself easily obtained from CBD.

    Route of preparation

    Chemical process

    No enzymatic route is described. In the plant and in extracts, the molecule is linked to the spontaneous oxidative aromatisation of Δ9-THC into cannabinol, of which it is a partially aromatised intermediate step (Hanuš et al. 2016). Its semi-synthetic preparation is a partial dehydrogenation of Δ9-THC, described here by class only.

    Classification

    Family, origin and source verification

    Family

    Semi-synthetic cannabinoid › Provisional classification

    Chemistry

    Type CBN · C5 side chain · neutral form

    Natural trace reported

    Hanuš et al. (2016) cite the isolation of partially aromatised derivatives such as 7,8-dihydrocannabinol (compound 41) in support of the artefactual origin of CBN-type cannabinoids (oxidative aromatisation of THC). An oxidation trace, not produced by the plant; the original isolation publication has not been identified.

    Hanuš LO, Meyer SM, Muñoz E, Taglialatela-Scafati O, Appendino G. Phytocannabinoids: a unified critical inventory. Nat Prod Rep 2016;33:1357-1392 (new tab)

    Verification

    Checked on 20 October 2026; some points still await human review.

    Wikipedia (English)

    7,8-Dihydrocannabinol (new tab)

    Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

    References

    Identifiers

    Names

    Common name
    7,8-Dihydrocannabinol
    IUPAC name
    6,6,9-trimethyl-3-pentyl-7,8-dihydrobenzo[c]chromen-1-ol
    Other names
    DHC · dihydrocannabinol · 6,6,9-trimethyl-3-pentyl-7,8-dihydrobenzo[c]chromen-1-ol

    Identifiers

    Formula
    C₂₁H₂₈O₂
    PubChem CID
    94376(new tab)
    InChIKey
    RECLSNODOVFMMU-UHFFFAOYSA-N
    SMILES
    CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(CC3)C)(C)C)O

    Machine-readable entry (JSON)

    LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.